Author:
Zou Hong-Yan,Wu Hai-Long,Zhang Yan,Li Shu-Fang,Nie Jin-Fang,Fu Hai-Yan,Yu Ru-Qin
Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference51 articles.
1. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) 4′-O-tetrahydropyranyladr-amycin as a potential new antitumor agent. Cancer Res 42(4):1462–1467
2. Kimura K (1986) A phase II study of (2″R) - 4′-O-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. Jpn J Cancer Chemother 13(2):368–375
3. Enomoto K, Abe O, Tominaga T, Abe R, Iino Y, Koyama H, Fujimoto M, Nomura Y (1990) Clinical study of pirarubicin for breast cancer in Japan. Clinical Study Group of THP for Breast Cancer in Japan. J Clin Oncol 13(Suppl 1):S48–S53
4. Izumi N, Goto Y (1990) A clinical trial of transarterial chemoembolization for hepatocellular carcinoma using 4′-O-tetrahydropyranyladriamycin. Jpn J Cancer Chemother 17(7):1303–1307
5. Carrasco C, Joubert A, Tardy C, Maestre N, Cacho M, Braña MF, Bailly C (2003) DNA sequence recognition by bispyrazinonaphthalimides antitumor agents. Biochemistry 42(40):11751–11761. doi: 10.1021/bi034637h
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献